Publications

Sort by: Date | Author | Title

Nygaard, U., Nielsen, A. B., Dungu, K. H. S., Drici, L., Holm, M., Ottenheijm, M. E., Nielsen, A. B., Glenthøj, J. P., Schmidt, L. S., Cortes, D., Jørgensen, I. M., Mogensen, T. H., Schmiegelow, K., Mann, M., Vissing, N. H. & Wewer Albrechtsen, N. J. (2024). Proteomic profiling reveals diagnostic signatures and pathogenic insights in multisystem inflammatory syndrome in children. Communications Biology, 7(1), Article 688. https://doi.org/10.1038/s42003-024-06370-8
Scofield, D., Frisch, M., Andersson, M., Storgaard, M., Pedersen, G., Johansen, I. S., Katzenstein, T. L., Graugaard, C., Omland, L. H., Weis, N. & Moseholm, E. (2024). Psychosocial and sexual health among men with and without HIV who have sex with men: A cross-sectional nationwide study in Denmark. HIV Medicine, 25(11), 1203-1217. https://doi.org/10.1111/hiv.13688
Johansen, N. D., Vaduganathan, M., Bhatt, A. S., Modin, D., Chatur, S., Claggett, B. L., Janstrup, K. H., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Køber, L., Solomon, S. D., Sivapalan, P., Jensen, J. U. S., Martel, C. J. M., Krause, T. G. & Biering-Sørensen, T. (2024). Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season. American Heart Journal, 272, 23-36. https://doi.org/10.1016/j.ahj.2024.03.003
Møller, M., Friis-Hansen, L., Kirkby, N., Dilling-Hansen, C., Andersson, M., Vedsted, P., Mølbak, K. & Koch, A. (2024). Robust immune response to COVID-19 vaccination in the island population of Greenland. Communications Medicine, 4(1), 173. Article 173. https://doi.org/10.1038/s43856-024-00602-y
Singh, K., Rubenstein, K., Callier, V., Shaw-Saliba, K., Rupert, A., Dewar, R., Laverdure, S., Highbarger, H., Lallemand, P., Huang, M.-L., Jerome, K. R., Sampoleo, R., Mills, M. G., Greninger, A. L., Juneja, K., Porter, D., Benson, C. A., Dempsey, W., El Sahly, H. M. ... Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members (2024). SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir. The Journal of Infectious Diseases, 230(3), 624-634. https://doi.org/10.1093/infdis/jiae198